跳至主要内容
临床试验/DRKS00028147
DRKS00028147尚未招募1 期

Effects of single and multiple oxygen administration under elevated ambient pressure on the healthy human kidney - RENOX

HBO-Zentrum Euregio Aachen0 个研究点目标入组 20 人开始时间: 2022年2月16日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • HBO therapy in the context of a hearing loss/ tinnitus
  • - No known previous kidney diseases
  • - No known vascular diseases
  • - GFR > 90m/min (via CKD-EPI)
  • - No use of permanent medication with influence on renal function
  • - Sufficient knowledge of German

排除标准

  • - GFR < 90ml/min
  • - Diseases with limitation of endocrine and exocrine renal function
  • - Known intolerance to high ambient pressures with inability to equalize pressure (via Valsalva maneuver). Exclusion is based on patient history and symptoms.
  • - Diseases of the middle ear
  • - claustrophobia
  • - Pulmonary disorders, such as severe bronchial asthma, emphysema, pneumothorax, acute infectious diseases
  • - Acute upper respiratory tract and/or sinus infections with sinunasal congestion (stuffy nose or rhinitis)
  • - Non-removable implants such as pacemakers, drug pumps, breast implants depending on manufacturer's instructions
  • - Pregnancy and lactation
  • - Severe cardiovascular diseases, in particular uncontrolled or poorly controlled arterial hypertension or heart failure
  • - Sickle cell anemia
  • - Condition following surgical procedures on the chest, ear or eye
  • - seizure disorders
  • - Taking medications that lower the seizure threshold (e.g., antidepressants)
  • - Persistent foramen ovale (PFO)
  • - Known vascular diseases

研究者

发起方
HBO-Zentrum Euregio Aachen

相似试验